| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/35.2.281 |
| P698 | PubMed publication ID | 7759392 |
| P50 | author | David M. Livermore | Q100272320 |
| P2093 | author name string | L M Hall | |
| D Gur | |||
| H E Akalin | |||
| F Danel | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | 281-294 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa | |
| P478 | volume | 35 |
| Q33594236 | A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil |
| Q39470757 | An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa |
| Q34568784 | Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center |
| Q35007624 | Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms |
| Q33834243 | Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital |
| Q31974278 | Antipseudomonal antibiotics. |
| Q39781579 | Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase |
| Q30764300 | Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases |
| Q35607689 | Complete nucleotide sequence of a conjugative plasmid carrying bla(PER-1). |
| Q36670323 | Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential |
| Q33972291 | Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase |
| Q35917817 | Emergence of integron borne PER-1 mediated extended spectrum cephalosporin resistance among nosocomial isolates of Gram-negative bacilli. |
| Q33770194 | Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria |
| Q35006613 | Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes |
| Q99594249 | In vitro activity of cefiderocol, a siderophore-cephalosporin, against multidrug-resistant gram-negative bacteria |
| Q34134689 | In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters |
| Q36933326 | Molecular Epidemiology and Genetic Characteristics of Various blaPER Genes in Shanghai, China |
| Q33976426 | Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene |
| Q33697910 | Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa |
| Q46735380 | Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital |
| Q34782040 | Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy |
| Q43633615 | Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns |
| Q35134964 | OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain |
| Q33702898 | OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates |
| Q39470875 | OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa |
| Q39785056 | OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. |
| Q36098603 | Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex |
| Q39784400 | Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region |
| Q34118028 | Resistance to antimicrobial agents in Mediterranean countries |
| Q39652923 | Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China |
| Q33938238 | Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants. |
| Q34047473 | Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium |
| Q39785102 | Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study |
| Q24669605 | beta-Lactamases in laboratory and clinical resistance |
Search more.